At FHE2025, Dr. Devin Zhu, Vice President of R&D at Wecare Probiotics, delivered a presentation titled "Development and Scaled Intelligent Manufacturing of Industrialized and Functional Probiotic Strains."
Dr. Zhu detailed Wecare's comprehensive approach to probiotic development, covering the entire value chain from strain selection to product commercialization. Additionally,
Dr. Zhou, R&D Engineer at Wecare, delivered a presentation titled "Application and Development of High-Activity Weizmannia coagulans BC99 in Health Products for Alcohol Protection and Liver Health."
Dr. Zhao, Product Application Technology Director at Wecare, delivered a presentation titled "Clinical Research Progress of Bifidobacterium animalis subsp. lactis BLa80." These presentations showcased Wecare Probiotics' latest advancements in probiotic research and application.
Leave a Message
Email
Linkedin